On the 17th of October, the FSETH 2019 fellowships of the Spanish Society of Hepatic Transplantation (SETH) were awarded in the framework of the 27th SETH Congress in Seville.The line of research on http://en.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=187002&t=Transplantaments%20Digestius digestive transplants of the Vall d'Hebron Research Institute (VHIR) and the Hepatobyliopancreatic Surgery Service and transplantation at the Vall d'Hebron Hospital led by Dr. Ramon Charco has been awarded a scholarship of 12.000 euros for the project "Profile of microRNA as a biomarker for liver damage in different types of liver donors" presented by resident Dr. Mar Dalmau and Dr. Concepción Gómez.The purpose of this scholarship is to help the liver transplant programs and to collaborate with the research and training of professionals from different specialties related to liver transplantation in the State.Certain microRNAs have appeared as potential early biomarkers of acute liver damage in the context of liver transplantation. In this sense, the project aims to analyze the levels of microRNA in different types of liver donor (giving in brain death, donating in controlled and live donation) in order to find a profile of expression of the microRNA to differentiate the different donors.A donor with brain death has no brain activity, the body continues to respond to an automatism because the heart is still pounding and therefore the organs remain perfect. They are usually elderly patients and more comorbidities. Instead, controlled donor donors are younger, have less comorbidities and tend to have brain injury with a poor prognosis. These patients have not passed a death brain and although brain damage is very serious, apparently, they may seem more like a living donor than a donor in brain death.Dr. Charco explains that "today there is no indicator that during the donor's maintenance inform us about the damage the liver is suffering from. The goal is to find an objective biomarker to tell us what is liver damage and see if there are differences between giving in brain death, living donor or controlled donor donation. This would make it more liberal when it comes to deciding whether a controlled donor is accepted as a donor "